Mereo BioPharma : UK Annual Report 2023 - MarketScreener

Company Number 09481161


MEREO BIOPHARMA GROUP PLC


Annual Report and Accounts


Year ended December 31, 2023

...

Related Keywords

London ,City Of ,United Kingdom ,United States ,Bishopsgate ,United Kingdom General ,America ,Feng Biosciences ,Justin Roberts ,Deepa Pakianathan ,Marc Yoskowitz ,Pierre Jacquet ,Denise Scots Knight ,Anders Ekblom ,Annalisa Jenkins ,Jeremy Bender ,Michael Wyzga ,Mark Dransfield ,Drug Administration ,Nasdaq ,Oncomed Pharmaceuticals ,Clinical Development Of Setrusumab ,University Of Alabama At Birmingham ,Latham Watkins ,Astrazeneca ,Mereo Biopharma Group ,Clinical Development Of Alvelestat ,Company Number ,Astraeus ,Company Balance Sheet ,European Medicines Agency ,Link Group ,Novartis ,Company Financial ,Division Of Pulmonary ,Exchange Commission ,Mereo Or Parent Company ,Health Status ,Director Responsibilities ,Cash Flows ,Consolidated Financial Statements ,Company Financial Statements ,Chief Executive Officer ,One Cavendish Place ,Central Square ,Biopharma Group ,Nasdaq Capital Market ,Companies Act ,Annual Report ,Foreign Private Issuer ,Drug Designation ,Fast Track ,Osteogenesis Imperfecta ,Treatment Landscape ,Priority Medicines ,Setrusumab Phase ,Cosmic Studies ,Associated Lung Disease ,Lung Disease ,Antitrypsin Deficiency ,North America ,Europe Regulatory ,Georges Respiratory Questionnaire ,Respiratory Health Status ,Respiratory Questionnaire ,Adverse Events ,Special Interest ,Professor Mark Dransfield ,Critical Care ,